Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating expenses:
Research and development	$ 2,425,898	$ 2,916,378
General and administrative	2,128,552	1,743,510
Depreciation	0	24,447
Loss from operations	4,554,450	4,684,335
Interest income	(27,809)	(40,416)
Net loss	$ (4,526,641)	$ (4,643,919)
Per share information:
Net loss per share of common stock, basic and diluted (in dollars per share)	$ (2.22)	$ (2.81)
Weighted average shares outstanding, basic and diluted (in shares)	2,038,323	1,649,969
Comprehensive loss:
Net loss	$ (4,526,641)	$ (4,643,919)
Unrealized loss on marketable securities	(49,658)	0
Comprehensive loss	$ (4,576,299)	$ (4,643,919)